AT-003(Arctic Therapeutics)

N/A

Report date: 2025/08/07 17:04:55
NME

Base Information

Drug NameAT-003(Arctic Therapeutics)
Drug Alias NameAT-003(Arctic Therapeutics)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionC-Type Lectin Domain Containing 16A modulators
TargetsC-Type Lectin Domain Containing 16A
Therapy Area/IndicationsDiabetes Mellitus, Type 1Lupus Erythematosus, SystemicParkinson Disease +[6] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIceland
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesArctic Therapeutics International
China Registration ClassN/A

Develop Information

Active CompaniesArctic Therapeutics International
Inactive CompaniesN/A
Active IndicationsDiabetes Mellitus, Type 1Lupus Erythematosus, SystemicParkinson Disease +[6] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A